Efficient Reversed-Phase Separation of Oligonucleotides by Using High pH Stable Superficially Porous Columns
Posters | 2016 | Agilent Technologies | HPLC SymposiumInstrumentation
Synthetic oligonucleotides are rapidly becoming key therapeutic agents, but their multi-step synthesis generates truncated impurities that challenge analytical laboratories. High-resolution, rapid and robust separation techniques are essential to ensure product purity and support drug development workflows.
This study evaluates a novel superficially porous reversed-phase column designed for stability at high pH. The goals are to assess its performance for RNA and DNA oligonucleotide separations and compare it to conventional totally porous C18 columns in terms of resolution, speed and backpressure.
The separations employed Agilent AdvanceBio Oligonucleotide superficially porous columns (2.1×50 mm, 2.7 µm). Mobile phases consisted of 100 mM triethylammonium acetate (TEAA) in water (A) and in acetonitrile (B), using a gradient from 10 % to 14 % B over 10 min. An alternative HFIP/TEA mobile phase for LC–MS compatibility was also tested. Chromatographic conditions included 65 °C column temperature, 0.6 mL/min flow rate and UV detection at 260 nm. An Agilent 1290 Infinity Binary pump and autosampler system was used throughout.
The superficially porous column achieved near-baseline separation of main oligonucleotides from N-1 and N-2 truncations for both RNA and DNA ladders within 10 min. Peak widths were narrower than those on a competitive 1.7 µm totally porous C18, indicating faster mass transfer. At equivalent resolution, backpressure on the 2.7 µm superficially porous column was ~108 bar versus ~292 bar on the 1.7 µm column, enabling compatibility with both 600 bar HPLC and 1200 bar UHPLC systems. Column durability was demonstrated over 300 consecutive injections of a 25-mer DNA oligo under pH > 8, with retention times and peak shapes remaining constant.
Advances may include the integration of superficially porous materials in next-generation UHPLC platforms to further increase throughput. Development of optimized buffer systems for direct MS coupling will streamline biopharma pipelines. Ongoing material science innovations may yield even smaller superficially porous particles with low backpressure and enhanced resolution.
High pH stable superficially porous HPLC columns deliver superior speed, resolution and durability for oligonucleotide separations compared to traditional totally porous columns, making them highly valuable for analytical laboratories in therapeutic development and quality control.
None provided.
HPLC, Consumables, LC columns
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Summary
Significance
Synthetic oligonucleotides are rapidly becoming key therapeutic agents, but their multi-step synthesis generates truncated impurities that challenge analytical laboratories. High-resolution, rapid and robust separation techniques are essential to ensure product purity and support drug development workflows.
Objectives and Study Overview
This study evaluates a novel superficially porous reversed-phase column designed for stability at high pH. The goals are to assess its performance for RNA and DNA oligonucleotide separations and compare it to conventional totally porous C18 columns in terms of resolution, speed and backpressure.
Methods and Used Instrumentation
The separations employed Agilent AdvanceBio Oligonucleotide superficially porous columns (2.1×50 mm, 2.7 µm). Mobile phases consisted of 100 mM triethylammonium acetate (TEAA) in water (A) and in acetonitrile (B), using a gradient from 10 % to 14 % B over 10 min. An alternative HFIP/TEA mobile phase for LC–MS compatibility was also tested. Chromatographic conditions included 65 °C column temperature, 0.6 mL/min flow rate and UV detection at 260 nm. An Agilent 1290 Infinity Binary pump and autosampler system was used throughout.
Main Results and Discussion
The superficially porous column achieved near-baseline separation of main oligonucleotides from N-1 and N-2 truncations for both RNA and DNA ladders within 10 min. Peak widths were narrower than those on a competitive 1.7 µm totally porous C18, indicating faster mass transfer. At equivalent resolution, backpressure on the 2.7 µm superficially porous column was ~108 bar versus ~292 bar on the 1.7 µm column, enabling compatibility with both 600 bar HPLC and 1200 bar UHPLC systems. Column durability was demonstrated over 300 consecutive injections of a 25-mer DNA oligo under pH > 8, with retention times and peak shapes remaining constant.
Benefits and Practical Applications
- High-throughput, high-resolution profiling of therapeutic oligonucleotides for QC and R&D.
- Compatibility with both UV and MS detection workflows.
- Extended column life under harsh, basic conditions.
Future Trends and Opportunities
Advances may include the integration of superficially porous materials in next-generation UHPLC platforms to further increase throughput. Development of optimized buffer systems for direct MS coupling will streamline biopharma pipelines. Ongoing material science innovations may yield even smaller superficially porous particles with low backpressure and enhanced resolution.
Conclusion
High pH stable superficially porous HPLC columns deliver superior speed, resolution and durability for oligonucleotide separations compared to traditional totally porous columns, making them highly valuable for analytical laboratories in therapeutic development and quality control.
References
None provided.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Evaluation of new high pH stable, superficially-porous particle columns for the reversed-phase separation of oligonucleotides
2015|Agilent Technologies|Posters
Evaluation of new high pH stable, superficially-porous particle columns for the reversed-phase separation of oligonucleotides HPLC 2015 PSB-BIOAN-07 Brian A. Bidlingmeyer, Xiaoli Wang, Stephen Luke* and Phu T Duong Agilent Technologies, Inc., 2850 Centerville Road, Wilmington, DE 19808, US and…
Key words
oligonucleotides, oligonucleotidesadvancebio, advancebiooligonucleotide, oligonucleotideporous, poroussuperficially, superficiallymin, minretention, retentiondna, dnaoligo, oligorna, rnasee, seetime, timecolumn, columnparticles, particlesconfidentiali
Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides
2017|Agilent Technologies|Applications
Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides High-pH-stable, superficially porous particle columns for LC/UV and LC/MS Application Note Biologics and Biosimilars Authors Introduction Phu Duong, Brian A. Bidlingmeyer, Synthetic DNA- and RNA-based oligonucleotides are among many successful biotherapeutic drugs…
Key words
ttttt, tttttoligonucleotide, oligonucleotideadvancebio, advancebiooligonucleotides, oligonucleotidesrna, rnadna, dnamau, maumin, minnmole, nmoleladder, laddersequence, sequenceretention, retentioncolumn, columnsuperficially, superficiallyteaa
Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards
2015|Agilent Technologies|Brochures and specifications
Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards IMPROVE RELIABILITY. REDUCE COSTS. INCREASE FLEXIBILITY. AGILENT ADVANCEBIO OLIGONUCLEOTIDE COLUMNS AND OLIGONUCLEOTIDE STANDARDS HIGH-RESOLUTION OLIGONUCLEOTIDE SEPARATIONS WITH LONG COLUMN LIFETIME ON HPLC AND UHPLC SYSTEMS Synthetic oligonucleotides are promising therapeutic agents for the…
Key words
oligonucleotide, oligonucleotideadvancebio, advancebioseparations, separationsagilent, agilentmau, mauoligonucleotides, oligonucleotidesoligo, oligotriethylammonium, triethylammoniumlifetime, lifetimerna, rnacolumns, columnsteaa, teaahexafluoroisopropanol, hexafluoroisopropanoldna, dnaresolution
Oligonucleotide Analysis: Practical Techniques and Method Development Optimization for HPLC
2023|Agilent Technologies|Presentations
Oligonucleotide Analysis: Practical Techniques and Method Development Optimization for HPLC Mohit Patel LC Columns and Consumables Technical Support December 19, 2023 1 12/19/2023 DE # DE48216954 What Are Oligonucleotide Therapeutic Types? Oligonucleotides are being increasingly developed as therapeutics against a…
Key words
oligonucleotide, oligonucleotideoligonucleotides, oligonucleotidesadvancebio, advancebiopair, pairladder, ladderbuffer, bufferresolution, resolutionmau, maurcrarcrurgrararurarcrcrararu, rcrarcrurgrararurarcrcrararurgrurcrarurcrarcrarcrurgrararurarcrcrararu, rgrurcrarurcrarcrarcrurgrararurarcrcrararururcrarcrarcrurgrararurarcrcrararu, rurcrarcrarcrurgrararurarcrcrararururcrarurcrarcrarcrurgrararurarcrcrararu, rurcrarurcrarcrarcrurgrararurarcrcrararuion, ionphase, phasebinding